Medtronic Acquiring Ardian - Stock Market Watch

Medtronic (NYSE:MDT) the medical device maker is proposing a $800 million deal to acquire Ardian. Ardian is a medical device maker with the latest high blood pressure catheter therapy. The deal is all cash payout. The Vice President of Medtronic, Sean Salmon stated that the deal also involves using Ardian’s technology to increase the annual revenue till the end of 2015.
Medtronic (NYSE:MDT) currently owns more than 11% stake in Ardian. The newest catheter blood pressure therapy received appreciation at the recent American Heart Association scientific meeting. It has managed to reduce blood pressure on an average by up to 33 points in high BP patients after 6 months.

Medtronic (NYSE:MDT) the medical device maker is proposing a $800 million deal to acquire Ardian. Ardian is a medical device maker with the latest high blood pressure catheter therapy. The deal is all cash payout. The Vice President of Medtronic, Sean Salmon stated that the deal also involves using Ardian’s technology to increase the annual revenue till the end of 2015.
Medtronic (NYSE:MDT) currently owns more than 11% stake in Ardian. The newest catheter blood pressure therapy received appreciation at the recent American Heart Association scientific meeting. It has managed to reduce blood pressure on an average by up to 33 points in high BP patients after 6 months.

« Return to Stock Market News «

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.